Mannose and amino acid compound for improving immunity

A compound, mannose technology, applied in the field of mannose-amino acid compound, can solve the problems of decreased immunity, single diet, etc., and achieve the effect of preventing sub-health state and improving immunity

Inactive Publication Date: 2019-06-07
汉肽生物医药集团有限公司
View PDF5 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0017] The most effective way to improve immunity is diet conditioning. However, due to the fast pace of life of modern people, the diet is s

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0029] Example 1: Preparation of mannose, arginine and citrulline complex particles

[0030] Take 1 kg of mannose, 0.3 kg of arginine and 0.6 kg of citrulline, mix thoroughly, pass a 150-mesh sieve, and add an appropriate amount of 20% povidone K30 solution. Making soft materials. The soft material is sieved and granulated, dried at 60°C, and granulated by a granulator to obtain granules.

Example Embodiment

[0031] Example 2: Preparation of mannose and citrulline complex particles

[0032] Take 1 kg of mannose and 0.6 kg of citrulline and thoroughly mix, pass through a 150-mesh sieve, and add an appropriate amount of 20% povidone K30 solution. Making soft materials. The soft material is sieved and granulated, dried at 60°C, and granulated by a granulator to obtain granules.

Example Embodiment

[0033] Example 3: Preparation of mannose and arginine complex particles

[0034] Take 1 kg of mannose and 0.3 kg of arginine and mix thoroughly, pass a 150-mesh sieve, and add an appropriate amount of 20% povidone K30 solution. Making soft materials. The soft material is sieved and granulated, dried at 60°C, and granulated by a granulator to obtain granules.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to the fields of foods and medicines. A compound of mannose, arginine and citrulline is adopted, so that the immunity can be effectively improved; and the three components are combined together, so that the compound has the effects of interpromomtion and coordination for improving immunity.

Description

technical field [0001] The invention relates to the field of food and medicine, in particular to a mannose-amino acid compound for improving immunity. Background technique [0002] Immunity is the body's own defense mechanism. It is the body's ability to recognize and eliminate any foreign bodies (viruses, bacteria, etc.) Ability is the physiological response of the human body to recognize and eliminate "dissidents". [0003] A body with a low immune system is prone to infection or cancer, and a body with a high immune system can also produce harmful results, such as triggering allergic reactions and autoimmune diseases. Various reasons make the immune system unable to play a protective role normally. In this case, it is very easy to cause infections such as bacteria, viruses, and fungi. Therefore, the most direct manifestation of low immunity is that it is easy to get sick. Frequent illnesses increase the consumption of the body Therefore, there are generally manifestatio...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A23L33/175A23L33/125A23G3/42A23G3/36A61K31/198A61K31/7048A61P37/00
Inventor 李同金赵传海周勇
Owner 汉肽生物医药集团有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products